JAMA Netw Open
Christopher Duane Nevala-Plagemann
- Medicare services, 2024
- 679
- Medicare patients, 2024
- 150
- Part D claims, 2024
- 359
- Publications
- 16
- MIPS score, 2024
- 90
- Practice address
- 50 North Medical Drive, Salt Lake City, UT 84132
- Practice phone
- Call (801) 581-2337
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University of Utah Hospitals and Clinics - Unit
Acute Care Hospital-Unit · Salt Lake City, Utah
Find Christopher Nevala-Plagemann's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Christopher Duane Nevala-Plagemann is a medical oncologist in Salt Lake City, Utah
Christopher Nevala-Plagemann practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.
Christopher Nevala-Plagemann's NPI, 1659725851, was assigned on April 14, 2016. Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016. Christopher Nevala-Plagemann holds Utah license 10514857-1205.
- NPI
- 1659725851NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2567728108
- NPI enumeration date
- April 14, 2016
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (801) 581-2337
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 36
- Medical school graduation
- 2016
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Christopher Duane Nevala-Plagemann practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah
Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.
- University of Utah Hospitals and Clinics - Unit50 North Medical Drive, Salt Lake City, UT 84132 · Salt Lake CountyPhone(801) 581-2337
Source: Dmand AI Affiliation Data
Christopher Duane Nevala-Plagemann is affiliated with 7 sites of care and 2 medical groups
Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Christopher Nevala-Plagemann is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Christopher Nevala-Plagemann to 3 more hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Christopher Duane Nevala-Plagemann's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Nevala-Plagemann practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Utah Hospitals and Clinics - Unit | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Christopher Duane Nevala-Plagemann is one of 39 medical oncologists in Utah
Medical oncology is Christopher Nevala-Plagemann's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Christopher Nevala-Plagemann is licensed in Utah.
Specialties and state licenses
- Medical oncology, UtahPrimary
Medical oncologists near Christopher Nevala-Plagemann
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Christopher Duane Nevala-Plagemann billed Medicare for 679 services in 2024
CMS data shows 679 Medicare services from Christopher Nevala-Plagemann across 8 procedure codes in 2024, for 150 Medicare patients. Medicare paid $41,440 for them.
Christopher Nevala-Plagemann's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3612024: 3764%
- Other services
- 2023: 1132024: 303168%
Where Christopher Nevala-Plagemann's Medicare services took place, 2024
- In an office49773%
- In a facility18227%
Christopher Nevala-Plagemann compared with the Utah median for medical oncologists, 2024
- Christopher Nevala-Plagemann
- Utah median
- Medicare services
- 679vs 6445% above
- Medicare patients
- 150vs 1389% above
- Part D claims
- 234vs 32929% below
Medians across 39 medical oncologists in Utah with Dmand AI profiles that report each measure.
Christopher Nevala-Plagemann's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Christopher Nevala-Plagemann?
Medicare shows one payer. Book a meeting to get commercial claims data for Christopher Nevala-Plagemann and other medical oncologists in Utah.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Christopher Duane Nevala-Plagemann treated 150 Medicare patients in 2024, average age 73
CMS counts 150 Medicare patients who saw Christopher Nevala-Plagemann in 2024. The largest group is 65 to 74, with 79 patients. 61% of them have high blood pressure, and 59% have cancer. 11% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Christopher Nevala-Plagemann's median patient age at 71, with 45% women.
Christopher Nevala-Plagemann's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Christopher Nevala-Plagemann's Medicare patients by sex, 2024
- Women6845%
- Men8255%
Chronic conditions among Christopher Nevala-Plagemann's Medicare patients, 2024
- High blood pressure61%
- Cancer59%
- High cholesterol44%
- Arthritis38%
- Diabetes28%
- Mood disorders27%
- Depression26%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Christopher Nevala-Plagemann's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women45%
- Men54%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Christopher Duane Nevala-Plagemann wrote 359 Medicare Part D claims in 2024
In 2024, Christopher Nevala-Plagemann wrote 359 Medicare Part D claims for 64 patients. 85% of them were for generic drugs. CMS names the drug for 234 of them, across 12 drugs with 11 or more claims each, at $254,545 in total drug cost. In 2023, CMS named 148 claims across 7 drugs.
Christopher Nevala-Plagemann's Part D claims by kind of drug, 2024
- Generic305 claims85%
- Brand-name54 claims15%
Christopher Nevala-Plagemann's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Christopher Nevala-Plagemann's Part D claims, 2024
- Opioids7%25 of 359 claims
- Antibiotics5%18 of 359 claims
- Antipsychotics, patients 65 and over3%11 of 359 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1482024: 23458%
Drugs named by CMS: 12 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Christopher Duane Nevala-Plagemann scored 90 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Christopher Nevala-Plagemann for performance year 2024, reported as part of a group. Christopher Nevala-Plagemann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Nevala-Plagemann as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Christopher Nevala-Plagemann's MIPS scores, performance year 2024
- 90of 100Final score
- 91.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Christopher Duane Nevala-Plagemann has 16 publications on record
Dmand AI links 16 papers to Christopher Nevala-Plagemann, published from 2018 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms and Carcinoma, Pancreatic Ductal. Christopher Nevala-Plagemann has published most often in J Natl Compr Canc Netw. Christopher Nevala-Plagemann's most frequent co-authors are Ignacio Garrido-Laguna, MD, Vaia Florou, MD and Siddharth K. Iyengar, MD.
Christopher Nevala-Plagemann's papers by year, 2018 to 2025
Topics Christopher Nevala-Plagemann writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Neoplasm Metastasis
- Adenocarcinoma
- Colorectal Neoplasms
- Fluorouracil
- Leucovorin
Christopher Nevala-Plagemann's most frequent co-authors
- Ignacio Garrido-Laguna, MD15 shared papers
- Vaia Florou, MD6 shared papers
- Siddharth K. Iyengar, MD2 shared papers
Recent publications by Christopher Nevala-Plagemann
J Natl Compr Canc Netw
See who Christopher Nevala-Plagemann researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Christopher Nevala-Plagemann works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Christopher Duane Nevala-Plagemann received $2,800 in industry payments from 2023 to 2024
CMS Open Payments shows 4 general payments to Christopher Nevala-Plagemann from 3 drug and device companies from 2023 to 2024. Consulting fees make up the largest share, 96% of the total. Seagen Inc. paid the most, $1,750.
General payments to Christopher Nevala-Plagemann by program year, 2023 to 2024
General payments to Christopher Nevala-Plagemann by kind, 2023 to 2024
- Consulting fees$2,67596%
- Food and beverage$1254%
Companies that paid Christopher Nevala-Plagemann the most, 2023 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Christopher Duane Nevala-Plagemann graduated from University of Minnesota Medical School
Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Christopher Duane Nevala-Plagemann's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Christopher Duane Nevala-Plagemann
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Christopher Duane Nevala-Plagemann's NPI number?
Christopher Duane Nevala-Plagemann's NPI number is 1659725851. It was assigned on April 14, 2016, and it is active in the NPI Registry.
What does Christopher Duane Nevala-Plagemann specialize in?
Christopher Duane Nevala-Plagemann is a medical oncologist in Salt Lake City, Utah. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Christopher Duane Nevala-Plagemann practice?
Christopher Nevala-Plagemann practices at 50 North Medical Drive, Salt Lake City, UT 84132. Christopher Nevala-Plagemann's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dmand AI also links Christopher Nevala-Plagemann to 3 hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group.
What is Christopher Duane Nevala-Plagemann's office phone number?
The practice phone on file for Christopher Nevala-Plagemann is (801) 581-2337.
What is Christopher Duane Nevala-Plagemann's medical license number?
Christopher Nevala-Plagemann holds Utah license 10514857-1205.
Which hospitals is Christopher Duane Nevala-Plagemann affiliated with?
Christopher Nevala-Plagemann is affiliated with University of Utah Hospital. Dmand AI links Christopher Nevala-Plagemann to 4 more hospitals.
What medical group is Christopher Duane Nevala-Plagemann part of?
Christopher Nevala-Plagemann is linked to University of Utah Health. Dmand AI links Christopher Nevala-Plagemann to 1 more medical group.
Does Christopher Duane Nevala-Plagemann accept Medicare?
Yes. CMS data shows Christopher Nevala-Plagemann billed Medicare for 679 services in 2024, and Christopher Nevala-Plagemann accepts Medicare assignment.
Does Christopher Duane Nevala-Plagemann offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Christopher Nevala-Plagemann as offering telehealth services.
What is Christopher Duane Nevala-Plagemann's MIPS score?
Christopher Nevala-Plagemann's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Christopher Duane Nevala-Plagemann see?
CMS counts 150 Medicare patients who saw Christopher Nevala-Plagemann in 2024, with an average age of 73.
What services does Christopher Duane Nevala-Plagemann bill to Medicare?
In 2024, Christopher Nevala-Plagemann's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
Where did Christopher Duane Nevala-Plagemann go to medical school?
Christopher Nevala-Plagemann graduated from University of Minnesota Medical School in 2016.
What drugs does Christopher Duane Nevala-Plagemann prescribe most?
In 2024 Medicare Part D data, Christopher Nevala-Plagemann's most prescribed drugs by claims were Ondansetron HCl, Prochlorperazine Maleate and Dexamethasone.
Has Christopher Duane Nevala-Plagemann received payments from drug or device companies?
CMS Open Payments shows $2,800 in general payments to Christopher Nevala-Plagemann from 3 companies from 2023 to 2024. The largest total came from Seagen Inc.
How long has Christopher Duane Nevala-Plagemann been practicing?
Christopher Nevala-Plagemann graduated from medical school in 2016, 10 years ago.
Does Christopher Duane Nevala-Plagemann do research?
Dmand AI links 16 publications to Christopher Nevala-Plagemann, published from 2018 to 2025.
Who does Christopher Duane Nevala-Plagemann publish with?
Christopher Nevala-Plagemann's most frequent co-authors are Ignacio Garrido-Laguna, MD (15 shared papers), Vaia Florou, MD (6 shared papers) and Siddharth K. Iyengar, MD (2 shared papers).
Selling to medical oncology practices?
See medical oncologists in Utah by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card